IP Library Granted Patent US 8,252,053
Granted Patent B2
US 8,252,053 · App. 13/005,220 · Granted Aug 28, 2012

Intraocular lens injector apparatus and methods of use

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,252,053
App. No.
13/005,220
Granted
Aug 28, 2012
Kind
B2
Abstract

An IOL injector kit comprising a first body portion having a first lumen disposed therethrough, a proximal end, a distal end configured to deposit an IOL into an eye, a second body portion having a second lumen disposed therethrough, a proximal end and distal end, a container comprising a wall defining a container lumen, a first open end configured to receive the proximal end of the first body portion into the container lumen, and a second open end configured to receive the distal end of the second body portion into the container lumen, and an IOL disposed inside said container.

Claims (11)

1. A method of loading an IOL injector with an IOL, the IOL injector comprising a proximal body portion and a distal body portion comprising:

providing a container containing an IOL, the container comprising a first end of the container and a second end of the container, and a container lumen, providing the container in a sealed state, the container comprising a first end cover and a second end cover configured to seal said first end and said second end respectively;

inserting the proximal body portion into the container lumen through the first end; inserting the distal body portion into the container lumen through the second end; removing the first end cover prior to the step of inserting the proximal body portion; and removing the second end cover prior to the step of inserting the distal body portion.

2. The method of claim 1 , wherein the container includes a holding apparatus disposed therein, the method further comprises connecting the proximal body portion to the proximal end of the holding apparatus.

3. The method of claim 2 , further comprising connecting the distal body portion to the proximal body portion without contacting the holding apparatus.

4. The method of claim 1 , wherein the container includes a holding apparatus disposed therein, the method further comprises connecting the distal body portion to the distal end of the holding apparatus.

5. The method of claim 4 , further comprising connecting the proximal body portion to the distal body portion without contacting the holding apparatus.

6. The method of claim 1 , wherein the step of inserting the proximal body portion into the lumen comprises connecting the proximal body portion to the container.

7. The method of claim 1 , wherein the step of inserting the distal body portion into the lumen comprises connecting the distal body portion to the container.

8. The method of claim 1 , wherein the step of inserting the proximal body portion occurs before the step of inserting the distal body portion.

9. The method of claim 1 , wherein the step of inserting the distal body portion occurs before the step of inserting the proximal body portion.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Apr 8, 2025
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: SOLTA MEDICAL, INC.; PRECISION DERMATOLOGY, INC.; BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED); SALIX PHARMACEUTICALS, INC.; SALIX PHARMACEUTICALS, LTD; SANTARUS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; HUMAX PHARMACEUTICAL S.A.; SOLTA MEDICAL IRELAND LIMITED; BAUSCH & LOMB MEXICO, S.A. DE C.V.; BAUSCH+LOMB OPS B.V.; BAUSCH HEALTH AMERICAS, INC.; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH HOLDCO LIMITED; BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC); BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA); BAUSCH HEALTH US, LLC; BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.; ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.); ORAPHARMA, INC.; PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.); SOLTA MEDICAL DUTCH HOLDINGS B.V.; V-BAC HOLDING CORP.; VRX HOLDCO LLC; 1261229 B.C. LTD.; 1530065 B.C. LTD.
Reel/Frame 070778/0199 →
RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS (REEL/FRAME 034749/0689) Recorded Oct 26, 2022
From: BARCLAYS BANK PLC
To: BAUSCH & LOMB INCORPORATED; UNIVERSITY OF ROCHESTER
Reel/Frame 061778/0146 →
NOTICE OF SUCCESSION OF AGENCY Recorded Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
SECURITY AGREEMENT Recorded Sep 4, 2013
From: BAUSCH & LOMB INCORPORATED
To: GOLDMAN SACHS LENDING PARTNERS LLC, AS COLLATERAL AGENT
Reel/Frame 031156/0508 →
RELEASE OF SECURITY INTEREST Recorded Aug 13, 2013
From: CITIBANK N.A., AS ADMINISTRATIVE AGENT
To: WP PRISM INC. (N/K/A BAUSCH & LOMB HOLDINGS INC.); BAUSCH & LOMB INCORPORATED; ISTA PHARMACEUTICALS
Reel/Frame 030995/0444 →
SECURITY AGREEMENT Recorded Nov 14, 2012
From: BAUSCH & LOMB INCORPORATED
To: CITIBANK N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 029295/0094 →
SECURITY AGREEMENT Recorded Aug 6, 2012
From: BAUSCH & LOMB INCORPORATED; EYEONICS, INC.
To: CITIBANK N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 028728/0645 →